Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source
twitter: 3 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 77 Dimensions

Readers on

mendeley: 256 Mendeley

Summary Policy documents X Wikipedia Dimensions citations

So far, Dimensions has found 77 publications that cite this research output.

77

The most recent citing publications are shown below. View all 77 publications that cite this research output on Dimensions.

Infliximab for maintenance of medically‐induced remission in Crohn's disease

Article in Cochrane Database of Systematic Reviews (February 2024)

Crohn's disease and clinical management today: How it does?

Article in World Journal of Methodology (December 2023)

Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions

Article in Clinical and Experimental Gastroenterology (December 2023)